NasdaqCM - Delayed Quote USD

Eloxx Pharmaceuticals, Inc. (ELOX)

12.44 -0.36 (-2.81%)

At close: November 6 at 4:00:00 PM EST

Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.

Individual or Entity	Most Recent Transaction	Date	Shares Owned as of Transaction Date
AGGARWAL SUMIT Chief Executive Officer	Conversion of Exercise of derivative security	Feb 27, 2026	1,672,760
ANDROSKI LINDSAY J.D. Director	Conversion of Exercise of derivative security	Jan 24, 2025	15,750
RUBIN STEVEN DANIEL Director	Conversion of Exercise of derivative security	Jan 23, 2026	14,625
WALTS ALAN EDMUND PH.D. Director	Conversion of Exercise of derivative security	Jan 23, 2026	15,567